ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "TH17 Cells"

  • Abstract Number: 1756 • ACR Convergence 2025

    Exosomal Cargo and Surface Markers: Informative Signals in Axial Spondyloarthritis

    Fataneh Tavasolian1, star lively2, chiara Pastrello3, Melissa Lim1, Addison Pacheco4, Zoya Qaiyum5, Michael Tang4, Zeynep Baskurt3, Igor Jurisica6, Mohit Kapoor5 and Robert Inman4, 1University of Toronto, Toronto, ON, Canada, 2University Heaklth Network, Toronto, 3University Health Network, Toronto, 4University Health Network, Toronto, ON, Canada, 5Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada, 6University Health Network, Toronto, Canada

    Background/Purpose: Exosomes are small extracellular vesicles carrying surface molecules and molecular cargo, including microRNAs (miRNAs), that mediate intercellular communication. Both the exosomal cargo and surface…
  • Abstract Number: 2583 • ACR Convergence 2025

    CCL20+ monocytes expanded by HLA-B*27 fuel Th17 generation in Axial Spondyloarthritis

    Jinyi Zhao1, Feng Liu2, Hui Shi3, Liye Chen1 and Paul Bowness4, 1Botnar Research Center, University of Oxford, Oxford, United Kingdom, 2University of Oxford, Oxford, United Kingdom, 3Botnar Research Center, University of Oxford, Oxford, England, United Kingdom, 4NIHR Oxford Biomedical Research Centre, University of Oxford, NDORMS, Oxford, United Kingdom

    Background/Purpose: Axial spondyloarthritis (AxSpA) is a chronic inflammatory arthritis characterized by monocyte activation and Th17 cell expansion. While HLA-B*27 is the strongest genetic risk factor…
  • Abstract Number: 2688 • ACR Convergence 2025

    Single cell RNA-seq immune profiling of blood samples from a psoriatic disease clinical trial reveals a CD4 T cell population associated with response to IL-23 blockade

    Kathryne Marks1, Anina Sun2, Ifeoluwakiisi Adejoorin1, Lourdes Perez Chada3, Anna Perillo4, Leanne Barrett2, Michael Garshick5, James Krueger6, Joseph Merola7, Marcelo DiCarli2, Deepak Rao1 and Brittany Weber8, 1Brigham and Women's Hospital, Boston, MA, 2Brigham And Women's Hospital, Boston, 3Harvard Medical School, Wayland, MA, 4The Rockefeller University, New York, NY, USA, New York, NY, 5NYU Langone Health, Tenafly, NJ, 6Rockefeller University, New York, NY, 7UT Southwestern Medical Center, Dallas, TX, 8Brigham and Women's Hospital, DEDHAM, MA

    Background/Purpose: The use of IL-23 inhibitors (IL-23i) for psoriatic diseases resulted in significant improvement in disease symptoms for many patients. Whether any blood immune cell…
  • Abstract Number: 0101 • ACR Convergence 2025

    Enrichment of putative bacteria-reactive gut-derived IL-17+ tissue resident memory helper T cells in arthritic ankles in the SKG mouse model of spondyloarthritis

    Benjamin Cai1, Megan Soon2, Zewen Kelvin Tuong2, Mark Morrison2, Anne-Sophie Bergot3 and Ranjeny Thomas4, 1Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia, 2Frazer Institute, The University of Queensland, Brisbane, Australia, 3Frazer Institute, The University of Queensland, Woolloongabba, Queensland, Australia, 4Frazer Institute, University of Queensland, Brisbane, Queensland, Australia

    Background/Purpose: In spondyloarthropathy (SpA), arthritis is often associated with gut inflammation. The strong genetic association with HLA-B27 implicates involvement of T cells, but how gut…
  • Abstract Number: 0106 • ACR Convergence 2025

    Investigation of DNA Methylation Inhibition in a Mouse Model of Ankylosing Spondylitis

    Goh Murayama1, Kurisu Tada2, Naoto Tamura3, Eri Hayashi1, Taiga Kuga4, Ken Yamaji5 and HOSHIKO FURUSAWA6, 1Department of Internal Medicine and Rheumatology, Juntendo University Graduate School of Medicine, Tokyo, Japan, 2Department of Internal Medicine and Rheumatology, Juntendo University Graduate School of Medicine, Tokyo, 3Juntendo University School of Medicine, Tokyo, Japan, 4Juntendo University, Tokyo, Japan, 5Juntendo University, Department of Internal Medicine and Rheumatology, Tokyo, Japan, 6juntendo, tokyo, Japan

    Background/Purpose: Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by enthesitis in axial joints, bone erosion near the entheses, and subsequent irreversible ankylosis due…
  • Abstract Number: 0800 • ACR Convergence 2025

    Microbiota-Derived Indole Promotes Collagen-Induced Arthritis Type-17 Immunity through Intestinal Dendritic Cell Cytokine Production

    Jing Jing Li1, Sucai Liu2, Brenda Seymour3, Brendan Allen2, Le Yiphyo2, Cassandra Levens1 and Kristine Kuhn4, 1Rheumatology, Aurora, CO, 2University of Colorado School of Medicine, Aurora, CO, 3University of Colorado School of Medicine, Denver, CO, 42022 - 2023 / Adult/ University of Colorado, Aurora, CO

    Background/Purpose: One of the most substantial impacts of microbe-host interactions at the intestinal mucosa is the development of type 17 immunity. A Th17 signature has…
  • Abstract Number: 0978 • ACR Convergence 2025

    IL-17A+ HLA-DR-CCR6+ regulatory T cells: Dual role in T cell suppression and synovial inflammation in arthritis.

    Bennie Heeswijk1, Margot Bongenaar1, Nadine Davelaar1, Pascal de Jong1, Hannah den Braanker1, Radboud Dolhain1 and Erik Lubberts2, 1Erasmus University Medical Center, Rotterdam, the Netherlands, Rotterdam, Netherlands, 2Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands

    Background/Purpose: Regulatory T cells (Tregs) are essential for maintaining immune tolerance and limiting excessive immune responses. However, Tregs show high levels of heterogeneity and plasticity,…
  • Abstract Number: 0979 • ACR Convergence 2025

    IL-23 upregulates IFN-γ secretion in Th17.1, but not in Th17 or classical Th1 cells

    Bennie van Heeswijk1, Wida Razawy2, Anne-Marie Mus-Otten3, Patrick Asmawidjaja2, Pieter Leenen2 and Erik Lubberts4, 1Erasmus MC, University Medical Center Rotterdam, Hoofddorp, Netherlands, 2Erasmus University Medical Center, Rotterdam, the Netherlands, Rotterdam, Netherlands, 3Erasmus medical center, Rotterdam, Netherlands, 4Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands

    Background/Purpose: Interleukin-23 (IL-23) is a key cytokine in the pathogenesis of psoriatic diseases, as demonstrated by the clinical success of IL-23-targeted therapies. Monocytes are a…
  • Abstract Number: 0991 • ACR Convergence 2025

    MTHFD2 is a Novel Metabolic Target in Autoimmune Disease

    Laura McMillan, Celia Evans, Marina Makrecka-Kuka, Niamh Richmond, Gareth Davies, Hamel Patel, Michael Herdman, Mark Whitmarsh, Alessandro Mazzacani, Peter Bunyard, Madduri Ravin Rao and Iain Kilty, Sitryx Therapeutics, Oxford, United Kingdom

    Background/Purpose: Aberrant activation and persistence of adaptive immune responses play a central role in autoimmune pathogenesis. Where traditional immunosuppressive therapies offer a broad targeting approach,…
  • Abstract Number: 0993 • ACR Convergence 2025

    NOD2 mutations mediate IL-17 predisposition in patients with Blau syndrome

    Leah Huey1, Emily Vance2, Bryce Binstadt3 and Ruth Napier2, 1Oregon Health & Science University, Denver, CO, 2University of Colorado Anschutz, Aurora, CO, 3University of Minnesota, Minneapolis, MN

    Background/Purpose: Blau syndrome is a pediatric rheumatic disease characterized by dermatitis, arthritis, and uveitis. Blau syndrome is caused by inborn or de novo mutations in…
  • Abstract Number: 0998 • ACR Convergence 2025

    Preclinical Characterization of a Novel Bi-specific Antibody Targeting IL-23p19 and IL-36R for The Treatment of Autoimmune Diseases

    qianqian yin1, changqing run1, kaili liu1, xueqin cui1, fanpeng Meng1, yanru fan1, yifei yang1, wei ye1, Lu Su2, yuan lin1 and cheng liao1, 1Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China (People's Republic), 2Jiangsu Hengrui Pharmaceuticals, Shanghai, Shanghai, China

    Background/Purpose: IL-23 is a pivotal cytokine driving IL-17-mediated inflammation, and its inhibition has shown efficacy in Th17-associated autoimmune diseases. However, patient heterogeneity and compensatory pathways…
  • Abstract Number: 1094 • ACR Convergence 2025

    Changes in NK cells and TH cell phenotype in Rheumatoid Arthritis patients treated with janus kinase inhibitors: implications for adverse effects

    Carmen Lasa Teja1, Juan José Fernández-Cabero2, Alejandra Comins-Boo3, David San Segundo3, Virginia Portilla González4, Montserrat Santos-Gomez5, José Luis Martín-Varillas6, Marcos López-Hoyos3 and Ricardo Blanco7, 1Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Riotuerto, Cantabria, Spain, 2Division of Immunology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander , Spain, Santander, Cantabria, Spain, 3Division of Immunology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander , Spain, Santander, Spain, 4Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander , Spain, Santander, 5Division of Immunology, Hospital Sierrallana. Santander , Spain, Santander, Spain, 6Rheumatology Division, Hospital de Laredo. IDIVAL, Immunopathology Group. Santander, Spain., Laredo, Spain, 7Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain

    Background/Purpose: Janus kinase inhibitors (JAKi) are effective in rheumatoid arthritis (RA); however, concerns regarding safety, particularly the risk of infections and malignancies, have been raised.…
  • Abstract Number: 1441 • ACR Convergence 2025

    Efficacy and Safety of Vunakizumab in Patients with Active Ankylosing Spondylitis by Cigarette Smoking Status: A Post Hoc Analysis of a Randomized, Double-blind, Phase 2/3 Study

    Hongbin Li1 and Huilin Li2, 1Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Nei Mongol, China (People's Republic), 2Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China (People's Republic)

    Background/Purpose: Vunakizumab, a humanized anti-interleukin-17A monoclonal antibody, has shown significant efficacy and favorable safety in patients with active ankylosing spondylitis (AS), leading to its approval…
  • Abstract Number: 1622 • ACR Convergence 2025

    Defective CD4+ regulatory T cells in active Takayasu arteritis patients can be improved by efficiency treatment of tofacitinib

    jing luo1 and Lan He2, 1the first affiliated hospital of xi'an jiaotong university, xi'an, China (People's Republic), 2The First Affiliated Hospital of Xi’an Jiaotong University, Xi'an, China (People's Republic)

    Background/Purpose: To investigate the efficacy of tofacitinib (TOF) in patients with active TAK, explore the effect on CD4+ regulatory T cells (Tregs) homeostasis and relationship…
  • Abstract Number: 1754 • ACR Convergence 2025

    B3GNT2 Regulates Integrin β3 Glycosylation and Th17/Treg Imbalance in Axial Spondyloarthritis Pathogenesis

    Chengchun Geng1, Dachun Zhuo1, Jiucun Wang2 and Jing Liu1, 1Fudan University, Shanghai, Shanghai, China (People's Republic), 2Fudan University, Shanghai, China (People's Republic)

    Background/Purpose: The rs6759298 variant near B3GNT2 is associated with Axial Spondyloarthritis (AS); however, its pathogenic mechanisms remain unknown. In this study, we explored the role…
  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology